My Three Months With Wegovy: What It Taught Me About Food, Fear, and Long-Term Change

Medical Disclaimer: I am not a doctor, and this article is not medical advice. This is a personal account of my experience with Wegovy. Everyone’s body, health history, and circumstances are different. If you’re considering or currently using a GLP-1 medication, please consult a qualified healthcare professional.

I want to start by saying something important up front: this is not an anti-Wegovy article.

It’s also not a glowing endorsement. It’s simply the story of my experience, three months, one auto-injector, a lot of nausea, and a handful of questions that ultimately led me in a different direction.

If GLP-1 medications like Wegovy, Ozempic, or others have been life-changing for you, I truly mean that when I say I’m glad they exist. For some people, these medications are absolutely a lifeline. This is just my op-ed, one person’s lived experience, thoughts, and conclusions.

The Needle Problem (Right Out of the Gate)

Let’s get this out of the way: I don’t like needles.

I don’t hate them in a dramatic, fainting-goat way, but I don’t enjoy them, and I don’t find them empowering or exciting. So when I was handed a Wegovy auto-injector in early 2025, “intimidated” feels like a fair word.

At the time, I wasn’t really given much instruction on how or where to inject. And to be fair, this was early 2025, there wasn’t nearly as much real-world content floating around online yet. No endless TikToks. No detailed Reddit threads. Just a pamphlet and a vague sense of, “You’ll figure it out.”

I tried my upper arm. I tried my thigh.

Both were considered acceptable injection sites at the time, and both technically worked. But I never got used to the discomfort. Every week felt like a small mental hurdle. I didn’t dread it enough to quit immediately, but I also never found my rhythm with it.

Appetite Suppression… or Something Else?

Yes, Wegovy curbed my appetite. But not in the way I expected. I never really felt full. I didn’t experience that calm, satisfied feeling where you push a plate away and think, “I’m good.” What I felt instead was nausea. Constant, low-grade, ever-present nausea. The kind where you always feel like you might get sick, but usually don’t.

The entire time I was on the GLP-1, I felt like I was walking around with a stomach bug that never quite bloomed into full illness but never left either. On the rare occasions when I wasn’t nauseous, I didn’t feel especially disinterested in food. I could still eat. I could still overeat.

So while the medication technically suppressed appetite, the mechanism, for me, felt less like regulation and more like avoidance. I wasn’t choosing less food because I felt satisfied. I was choosing less food because I felt unwell.

And that distinction mattered to me.

Minimal Results, Major Questions

After three months, my weight loss was minimal.

Not zero, but not enough to outweigh how unpleasant the experience felt overall. And during that time, a bigger concern kept circling in my mind. I couldn’t shake the feeling that I was trading one dependency for another. Food had clearly been an issue for me, otherwise, I wouldn’t have been there in the first place. But using a weekly injection to manage my relationship with food raised a question I couldn’t ignore:

What happens if this works?

Am I tied to this shot forever?

Have I solved the problem, or have I just created a new one?

The metaphor that kept popping into my head went something like this:

We didn’t have a rat problem anymore… because we got cats. Then the cats became a problem, so we got dogs. But now we’ve got alligators, and nobody knows what to do with those.

That’s how it felt.

Sure, something was being controlled. But at what cost? And for how long?

The Long Game Started to Matter More Than the Shortcut

I started thinking about sustainability.

What do the long-term effects of GLP-1 usage look like when we have decades of data, not just years? How do people eventually come off these medications? What happens to the weight if lifestyles don’t change alongside the chemistry?

Those questions don’t have clear answers yet and that uncertainty made me uncomfortable.

For me, the bigger realization was this: I needed to create a better situation, not just a faster result. I needed to improve my relationship with food, not outsource it entirely. I needed to use exercise not as punishment, but as a daily practice of taking care of my body. I wanted tools and skills I could carry forward without a prescription. That doesn’t mean it’s easy. It doesn’t mean it’s quick. It just means it felt more honest for me.

The Cost Factor (Because It Matters)

There’s also the very real, very practical issue of cost.

In early 2025, Wegovy cost my insurance roughly $1,600 per month. I honestly don’t know what the cost is now, and I sincerely hope it has come down. But even setting the number aside, it reinforced the same question: Is this something I could or would want to maintain indefinitely?

For me, the answer was no.

A more holistic approach, nutrition, movement, habit-building was simply a better fit for my life, my values, and my long-term goals.

Where I Ultimately Landed

After three months, I stopped Wegovy. Not because it’s “bad.” Not because it doesn’t work. But because it didn’t work for me, and more importantly, it didn’t align with how I wanted to build a healthier future.

This article isn’t a warning label or a soapbox. It’s just an honest reflection. GLP-1 medications are probably life-saving for some people. Truly. And I’m grateful they exist as an option. For me, though, the questions outweighed the benefits.

I wanted solutions that taught me something, not ones that replaced the problem with a different mechanism. I wanted skills I could keep, habits I could practice, and progress I could own.

And while that road may be longer, it’s the one that felt right for me.

If you’re considering Wegovy, or already on it, I hope this adds one more thoughtful perspective to the conversation. Not as truth. Not as advice. Just as one human story among many.